The mRNA COVID-19 vaccines developed by Pfizer and Moderna continue to save lives. But a new paper published in the journal Vaccines provides evidence that the two vaccines are not equivalent when it comes to protecting older ...
May 12, 2023
2
157
Though daily life has long returned to near-normal for many in the United States, the official end of the COVID-19 health emergency Thursday night still marks a new post-pandemic era for the country.
May 10, 2023
0
19
Vitamin D intake could reduce cancer mortality in the population by 12 percent—provided the vitamin is taken daily. This was the result of an evaluation of 14 studies of the highest quality conducted at the German Cancer ...
May 9, 2023
0
9
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
May 5, 2023
0
2
A small group of patients with type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, a medication used to treat erectile dysfunction. The result from the University ...
May 4, 2023
0
63
The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.
Apr 27, 2023
0
36
Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.
Apr 24, 2023
0
37
For children under age 18 years, a single computed tomography (CT) scan is not associated with an increased risk of brain tumours, leukemia or lymphoma, but exposure to 4 or more scans before adulthood more than doubles the ...
Apr 24, 2023
0
6
Scientists have uncovered a new understanding of how COVID-19 causes severe multi-organ injury in some patients and the pathways to stopping the cytokine storms behind them, according to new research published today in the ...
Apr 21, 2023
0
31
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of ...
Apr 17, 2023
0
2
